查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1529599

病人參與中的人工智慧市場規模、佔有率和趨勢分析報告：按技術、按交付類型、按功能、按治療領域、按最終用途、按地區、細分市場預測，2024-2030 年

AI In Patient Engagement Market Size, Share & Trends Analysis Report By Technology, By Delivery Type, By Functionality, By Therapeutic Area, By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

人工智慧市場成長與病人參與趨勢：

Grand View Research, Inc. 的最新報告顯示，到 2030 年，全球人工智慧病人參與市場規模預計將達到 231 億美元，2024 年至 2030 年複合年成長率為 21.2%。

該市場的推動因素包括對基於人工智慧的個人化治療計劃和醫療保健體驗的需求不斷成長，以及數位平台的出現和對全通路方法的需求。此外，人工智慧（AI）在市場參與者的商務策略中發揮越來越重要的作用，以提高藥房效率、管理供應鏈複雜性和業務策略，這也推動了市場的成長。例如，2024 年 5 月，EmpiRx Health 宣布推出 Clinically，這是一個新的人工智慧驅動平台，融合了現有技術。該平台為藥房申請處理和臨床評估提供支持，由專有的人口健康引擎提供支持，並為 EmpiRx Health 以臨床為重點的藥房福利管理 (PBM) 方法提供支援。

此外，糖尿病和高血壓等慢性病的盛行率不斷上升，需要患者持續參與和管理，而人工智慧可以有效促進這一點。此外，機器學習和自然語言處理 (NLP) 等人工智慧技術可以透過提供個人化支援和介入來顯著提高病人參與。這些技術分析患者資料並提供量身定做的建議、提醒和教育內容，以提高依從性和健康結果。例如，2022 年 3 月，Unifor 與病人參與解決方案提供者 SpinSci Technologies 建立了策略合作夥伴關係，以改善患者訪問以及與醫療保健提供者的互動。此次合作將 Unifor 的對話式人工智慧和自動化技術整合到 SpinSci Technologies 的患者訪問護理解決方案中，該解決方案與電子健康記錄(EHR) 系統相容。這種整合旨在提高客服中心代理效率並簡化患者自助服務工作流程。

人工智慧的整合使醫療保健提供者能夠根據患者的個人偏好、健康素養水平和語言熟練程度提供量身定做的教育內容，從而提高患者的參與度和治療計劃的依從性。例如，2024 年 2 月，Accolade Group 支援的創業平台 Ascend 宣布打算利用人工智慧提供針對特定需求的教育和醫療保健服務。由於這些努力，患者教育功能部分預計將顯著成長，並將推動未來幾年的整體市場擴張。

北美市場也將受益於人工智慧的整合，這將使醫療機構能夠根據患者的個人偏好、健康素養水平和語言熟練程度提供客製化的教育內容，從而提高患者的參與度和治療計劃的依從性。例如，2024 年 2 月，Accolade Group 支援的創業平台 Ascend 宣布打算利用人工智慧提供針對特定需求的教育和醫療保健服務。由於這些舉措，患者教育功能部分預計將顯著成長，並將推動未來幾年的整體市場擴張。

病人參與市場中的人工智慧報告亮點

  • 從交付形式來看，雲端基礎的細分市場佔據主導地位，2023 年收益佔有率為 72.37%。雲端基礎的解決方案提供可擴展的資源，使醫療保健組織能夠根據需求波動調整容量。
  • 按功能分類，通訊增強佔最大銷售佔有率，2023 年為 25.84%。人工智慧主導的解決方案在醫療保健領域的日益整合正在推動對增強通訊能力的需求。
  • 從技術來看，自然語言處理（NLP）佔最大收益佔有率， 2023年將達到88.82%。此細分市場的成長歸功於 NLP 模型提供的多項好處，例如透過提供量身定做且易於理解的健康資訊來提高病人參與和教育水平。
  • 以治療領域來看，慢病管理佔最大的銷售佔有率，2023年為64.87%。這一領域的成長是由於糖尿病、高血壓和心臟病等慢性病的盛行率不斷增加。
  • 按最終用途分類，醫療保健提供者產業在 2023 年佔據最大收益佔有率，達到 38.31%。對以患者為中心的護理的日益關注、對更好的資源利用的需求的增加以及對個性化醫療保健體驗的需求不斷成長正在推動醫療保健提供者採用人工智慧來促進病人參與。
  • 2023 年，北美市場佔據主導地位，佔有率為 43.60%。這一重要佔有率的關鍵因素包括擁有先進技術的成熟醫療基礎設施、人們對整合人工智慧病人參與解決方案的好處的認知不斷提高，以及個性化的醫療體驗和治療，其中包括對規劃的日益偏好。
  • 由於存在多個參與者，市場變得分散。因此，預計未來幾年競爭將會加劇。大公司擴大採取新產品開發、聯盟和併購等策略來鞏固其市場地位。 2024 年 6 月，MedAdvisor Solutions 宣布推出由 THRiV 提供支援的人工智慧平台全通路參與藥局。該套件使藥局能夠加強現有的工作，包括數位化病人參與策略和提供患者喜歡的無紙化選擇。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章：病人參與市場中的人工智慧變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 病人參與市場分析工具中的人工智慧 (AI)
    • 產業分析-波特五力分析
    • PESTEL分析
    • COVID-19 的影響
    • 案例研究

第 4 章病人參與的人工智慧市場估計和趨勢分析：按產品類型

  • 2023年及2030年市場佔有率
  • 細分儀表板
  • 全球市場展望
  • 雲端基礎
    • 2018年至2030年市場預測
  • 本地
    • 2018年至2030年市場預測

第5章病人參與的人工智慧市場估計和趨勢分析：按功能

  • 2023年及2030年市場佔有率
  • 細分儀表板
  • 全球市場展望
  • 加強溝通
    • 2018年至2030年市場預測
  • 病患教育
    • 2018年至2030年市場預測
  • Chabot 和虛擬健康助手
    • 2018年至2030年市場預測
  • 預測分析
    • 2018年至2030年市場預測
  • 管理和簡化營運
    • 2018年至2030年市場預測
  • 其他
    • 2018年至2030年市場預測

第 6 章病人參與方面的人工智慧市場估計和趨勢分析：按技術類型

  • 2023年及2030年市場佔有率
  • 細分儀表板
  • 全球市場展望
  • NLP
    • 2018年至2030年市場預測
    • 智慧援助
    • 光學字元辨識 (OCR)
    • 自動編碼
    • 文字分析
    • 語音分析
    • 分類與分類
  • 其他
    • 2018年至2030年市場預測

第 7 章病人參與的人工智慧市場估計和趨勢分析：按治療領域

  • 2023年及2030年市場佔有率
  • 細分儀表板
  • 全球市場展望
  • 健康與保健
    • 2018年至2030年市場預測
  • 慢性病管理
    • 2018年至2030年市場預測
  • 其他
    • 2018年至2030年市場預測

第 8 章病人參與中的人工智慧市場估計和趨勢分析：按最終用途

  • 2023年及2030年市場佔有率
  • 細分儀表板
  • 全球市場展望
  • 醫療服務提供方
    • 2018年至2030年市場預測
  • 醫療保健付款人
    • 2018年至2030年市場預測
  • 其他
    • 製藥公司
    • 藥局

第 9 章病人參與市場中的人工智慧區域估計和趨勢分析（按組件和技術類型）

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概述
  • 2018-2030年市場規模、預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 新加坡
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 創新者
  • 供應商情況
    • 2023年主要企業市場地位分析
    • Medadvisor Solutions
    • Innovaccer Inc.
    • EnlivenHealth（Omnicell）
    • EmpiRx Health
    • IBM.
    • Huma
    • mPulse Mobile
    • AllazoHealth
    • P360
    • Brand Engagement Network, Inc.
    • Oracle
    • Nuance Communications Inc.（Microsoft）
    • Health Catalyst
    • Ada Health GmbH
    • Aiva Inc.
    • Claritas Rx
    • AiCure
    • UST Global Inc.
    • ZS
    • IQVIA, Inc.
Product Code: GVR-4-68040-145-8

AI In Patient Engagement Market Growth & Trends:

The global AI in patient engagement market size is expected to reach USD 23.1 billion by 2030, registering a CAGR of 21.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by the growing demand for AI-based personalized treatment plans and healthcare experiences and the emergence of digital platforms and necessity for omnichannel approach. In addition, the increasing role of artificial intelligence (AI) in enhancing pharmacy efficiency and managing supply chain complexities and business strategies by market players is also driving the market growth. For instance, in May 2024, EmpiRx Health introduced Clinically, a new AI-powered platform that incorporates established technologies. This platform enhances pharmacy claims processing and clinical evaluations and includes a unique population health engine, reinforcing EmpiRx Health's clinical-focused Pharmacy Benefit Management (PBM) approach.

Moreover, the growing prevalence of chronic diseases, such as diabetes and hypertension, necessitates continuous patient engagement & management, which AI can effectively facilitate. Furthermore, AI technologies such as machine learning and natural language processing (NLP) can significantly enhance patient engagement by providing personalized support & interventions. These technologies analyze patient data to offer tailored recommendations, reminders, & educational content, improving adherence and health outcomes. For instance, in March 2022, Uniphore entered into a strategic partnership with SpinSci Technologies, a provider of digital patient engagement solutions, to improve patient access and interaction with healthcare providers. This collaboration integrated Uniphore's conversational AI and automation technology into SpinSci Technologies Patient Access Care solutions, which are compatible with Electronic Health Records (EHR) systems. The integration aimed to enhance efficiency for contact center agents and streamline patient self-service workflows.

The integration of AI enables healthcare organizations to deliver tailored educational content based on individual patient preferences, health literacy levels, and language proficiency, thereby improving patient engagement & adherence to treatment plans. For instance, in February 2024, Ascend, a startup platform backed by the Accolade Group, announced its intention to deliver educational and healthcare services tailored to specific requirements utilizing AI. As a result of such initiatives, the patient education functionality segment is expected to witness substantial growth, driving overall market expansion in the coming years.

In addition, the market in North America is driven by the integration of AI, enabling healthcare organizations to deliver tailored educational content based on individual patient preferences, health literacy levels, and language proficiency, thereby improving patient engagement & adherence to treatment plans. For instance, in February 2024, Ascend, a startup platform backed by the Accolade Group, announced its intention to deliver educational and healthcare services tailored to specific requirements utilizing AI. As a result of such initiatives, the patient education functionality segment is expected to witness substantial growth, driving overall market expansion in the coming years.

AI In Patient Engagement Market Report Highlights:

  • On the basis of delivery mode, the cloud-based segment dominated the market and held a revenue share of 72.37% in 2023. Cloud-based solutions provide scalable resources, enabling healthcare organizations to adjust capacity according to demand fluctuations
  • On the basis of functionality, enhanced communication held the largest revenue share of 25.84% in 2023. The growing integration of AI-driven solutions in the healthcare sector is driving the need for enhanced communication capabilities
  • On the basis of technology, Natural Language Processing (NLP) held the largest revenue share of 88.82% in 2023. The segment growth can be attributed to several benefits offered by NLP models such as improved patient engagement and education through the provision of tailored & comprehensible health information
  • On the basis of therapeutic area, chronic disease management held the largest revenue share of 64.87% in 2023. The segment growth can be attributed to the increasing prevalence of chronic conditions such as diabetes, hypertension, and heart disease
  • On the basis of end use, the healthcare providers segment held the largest revenue share of 38.31% in 2023. The increasing focus on patient-centric care, coupled with the growing need for effective use of resources and a rising demand for personalized healthcare experiences, is driving healthcare providers to adopt AI for patient engagement
  • North America dominated the market with a share of 43.60% in 2023. Key factors contributing to this notable share include the presence of a well-established healthcare infrastructure equipped with advanced technology, increasing awareness of the advantages of integrating AI-enabled patient engagement solutions, and a growing preference for personalized healthcare experiences & treatment plans
  • The market is fragmented owing to the presence of several players. This is expected to intensify the competition in the coming years. Key companies are increasingly adopting strategies such as new product development, collaborations, and mergers & acquisitions to strengthen their market position. In June 2024, MedAdvisor Solutions announced the launch of Omnichannel Engagement for Pharmacy powered by THRiV, its AI-enabled platform. This suite enables pharmacies to enhance their digital patient engagement strategies and existing initiatives, including providing paperless options increasingly preferred by patients

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. Therapeutic Area
    • 1.1.3. Functionality
    • 1.1.4. Delivery Type
    • 1.1.5. End Use
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology Outlook
    • 2.2.2. Therapeutic Area Outlook
    • 2.2.3. Functionality Outlook
    • 2.2.4. Delivery Outlook
    • 2.2.5. End Use Outlook
    • 2.2.6. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Artificial Intelligence (AI) in Patient Engagement Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Artificial Intelligence (AI) in Patient Engagement Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Impact of COVID-19
    • 3.3.4. Case Study

Chapter 4. Artificial Intelligence (AI) in Patient Engagement Market Delivery Type Estimates & Trend Analysis

  • 4.1. Delivery Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Artificial Intelligence (AI) in Patient Engagement Market by Delivery Type Outlook
  • 4.4. Cloud-based
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. On-premise
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Artificial Intelligence (AI) in Patient Engagement Market Functionality Estimates & Trend Analysis

  • 5.1. Functionality Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Artificial Intelligence (AI) in Patient Engagement Market by Functionality Outlook
  • 5.4. Enhanced Communication
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Patient Education
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Chabot & Virtual Health Assistants
    • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.7. Predictive Analytics
    • 5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.8. Administrative & Streamlined Operations
    • 5.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Artificial Intelligence (AI) in Patient Engagement Market Technology Type Estimates & Trend Analysis

  • 6.1. Technology Type Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Artificial Intelligence (AI) in Patient Engagement Market by Technology Type Outlook
  • 6.4. NLP
    • 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.2. Smart Assistance
      • 6.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.3. Optical Character Recognition (OCR)
      • 6.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.4. Auto Coding
      • 6.4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.5. Text Analytics
      • 6.4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.6. Speech Analytics
      • 6.4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.7. Classification & Categorization
      • 6.4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 6.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Artificial Intelligence (AI) in Patient Engagement Market Therapeutic Area Estimates & Trend Analysis

  • 7.1. Therapeutic Area Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Artificial Intelligence (AI) in Patient Engagement Market by Therapeutic Area Outlook
  • 7.4. Health & Wellness
    • 7.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 7.5. Chronic Disease Management
    • 7.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Artificial Intelligence (AI) in Patient Engagement Market End Use Estimates & Trend Analysis

  • 8.1. End Use Market Share, 2023 & 2030
  • 8.2. Segment Dashboard
  • 8.3. Global Artificial Intelligence (AI) in Patient Engagement Market by End Use Outlook
  • 8.4. Healthcare Provider
    • 8.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 8.5. Healthcare Payers
    • 8.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 8.6. Others
    • 8.6.1. Pharmaceutical Companies
      • 8.6.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 8.6.2. Pharmacy
      • 8.6.2.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 9. Artificial Intelligence (AI) in Patient Engagement Market Regional Estimates & Trend Analysis, By Component, By Technology Type

  • 9.1. Regional Market Share Analysis, 2023 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Global Regional Market Snapshot
  • 9.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 9.5. North America
    • 9.5.1. U.S.
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Regulatory framework/ reimbursement structure
      • 9.5.1.3. Competitive scenario
      • 9.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.2. Canada
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework/ reimbursement structure
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.3. Mexico
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework/ reimbursement structure
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6. Europe
    • 9.6.1. UK
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Regulatory framework/ reimbursement structure
      • 9.6.1.3. Competitive scenario
      • 9.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.2. Germany
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework/ reimbursement structure
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.3. France
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Regulatory framework/ reimbursement structure
      • 9.6.3.3. Competitive scenario
      • 9.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.4. Italy
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Regulatory framework/ reimbursement structure
      • 9.6.4.3. Competitive scenario
      • 9.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.5. Spain
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Regulatory framework/ reimbursement structure
      • 9.6.5.3. Competitive scenario
      • 9.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.6. Norway
      • 9.6.6.1. Key country dynamics
      • 9.6.6.2. Regulatory framework/ reimbursement structure
      • 9.6.6.3. Competitive scenario
      • 9.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.7. Sweden
      • 9.6.7.1. Key country dynamics
      • 9.6.7.2. Regulatory framework/ reimbursement structure
      • 9.6.7.3. Competitive scenario
      • 9.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.8. Denmark
      • 9.6.8.1. Key country dynamics
      • 9.6.8.2. Regulatory framework/ reimbursement structure
      • 9.6.8.3. Competitive scenario
      • 9.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7. Asia Pacific
    • 9.7.1. Japan
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Regulatory framework/ reimbursement structure
      • 9.7.1.3. Competitive scenario
      • 9.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.2. China
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework/ reimbursement structure
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.3. India
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework/ reimbursement structure
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.4. Australia
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Regulatory framework/ reimbursement structure
      • 9.7.4.3. Competitive scenario
      • 9.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.5. South Korea
      • 9.7.5.1. Key country dynamics
      • 9.7.5.2. Regulatory framework/ reimbursement structure
      • 9.7.5.3. Competitive scenario
      • 9.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.6. Singapore
      • 9.7.6.1. Key country dynamics
      • 9.7.6.2. Regulatory framework/ reimbursement structure
      • 9.7.6.3. Competitive scenario
      • 9.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8. Latin America
    • 9.8.1. Brazil
      • 9.8.1.1. Key country dynamics
      • 9.8.1.2. Regulatory framework/ reimbursement structure
      • 9.8.1.3. Competitive scenario
      • 9.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.2. Argentina
      • 9.8.2.1. Key country dynamics
      • 9.8.2.2. Regulatory framework/ reimbursement structure
      • 9.8.2.3. Competitive scenario
      • 9.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9. MEA
    • 9.9.1. South Africa
      • 9.9.1.1. Key country dynamics
      • 9.9.1.2. Regulatory framework/ reimbursement structure
      • 9.9.1.3. Competitive scenario
      • 9.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.9.2. Saudi Arabia
      • 9.9.2.1. Key country dynamics
      • 9.9.2.2. Regulatory framework/ reimbursement structure
      • 9.9.2.3. Competitive scenario
      • 9.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.9.3. UAE
      • 9.9.3.1. Key country dynamics
      • 9.9.3.2. Regulatory framework/ reimbursement structure
      • 9.9.3.3. Competitive scenario
      • 9.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.9.4. Kuwait
      • 9.9.4.1. Key country dynamics
      • 9.9.4.2. Regulatory framework/ reimbursement structure
      • 9.9.4.3. Competitive scenario
      • 9.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Company/Competition Categorization
  • 10.3. Innovators
  • 10.4. Vendor Landscape
    • 10.4.1. Key company market position analysis, 2023
    • 10.4.2. Medadvisor Solutions
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. Innovaccer Inc.
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. EnlivenHealth (Omnicell)
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. EmpiRx Health
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. IBM.
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Huma
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. mPulse Mobile
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. AllazoHealth
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. P360
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product benchmarking
      • 10.4.10.4. Strategic initiatives
    • 10.4.11. Brand Engagement Network, Inc.
      • 10.4.11.1. Company overview
      • 10.4.11.2. Financial performance
      • 10.4.11.3. Product benchmarking
      • 10.4.11.4. Strategic initiatives
    • 10.4.12. Oracle
      • 10.4.12.1. Company overview
      • 10.4.12.2. Financial performance
      • 10.4.12.3. Product benchmarking
      • 10.4.12.4. Strategic initiatives
    • 10.4.13. Nuance Communications Inc. (Microsoft)
      • 10.4.13.1. Company overview
      • 10.4.13.2. Financial performance
      • 10.4.13.3. Product benchmarking
      • 10.4.13.4. Strategic initiatives
    • 10.4.14. Health Catalyst
      • 10.4.14.1. Company overview
      • 10.4.14.2. Financial performance
      • 10.4.14.3. Product benchmarking
      • 10.4.14.4. Strategic initiatives
    • 10.4.15. Ada Health GmbH
      • 10.4.15.1. Company overview
      • 10.4.15.2. Financial performance
      • 10.4.15.3. Product benchmarking
      • 10.4.15.4. Strategic initiatives
    • 10.4.16. Aiva Inc.
      • 10.4.16.1. Company overview
      • 10.4.16.2. Financial performance
      • 10.4.16.3. Product benchmarking
      • 10.4.16.4. Strategic initiatives
    • 10.4.17. Claritas Rx
      • 10.4.17.1. Company overview
      • 10.4.17.2. Financial performance
      • 10.4.17.3. Product benchmarking
      • 10.4.17.4. Strategic initiatives
    • 10.4.18. AiCure
      • 10.4.18.1. Company overview
      • 10.4.18.2. Financial performance
      • 10.4.18.3. Product benchmarking
      • 10.4.18.4. Strategic initiatives
    • 10.4.19. UST Global Inc.
      • 10.4.19.1. Company overview
      • 10.4.19.2. Financial performance
      • 10.4.19.3. Product benchmarking
      • 10.4.19.4. Strategic initiatives
    • 10.4.20. ZS
      • 10.4.20.1. Company overview
      • 10.4.20.2. Financial performance
      • 10.4.20.3. Product benchmarking
      • 10.4.20.4. Strategic initiatives
    • 10.4.21. IQVIA, Inc.
      • 10.4.21.1. Company overview
      • 10.4.21.2. Financial performance
      • 10.4.21.3. Product benchmarking
      • 10.4.21.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America AI in patient engagement market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 4 North America AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 5 North America AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 6 North America AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 7 North America AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 U.S. AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 9 U.S. AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 10 U.S. AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 11 U.S. AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 12 U.S. AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Canada AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 14 Canada AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 15 Canada AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 16 Canada AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 17 Canada AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Mexico AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 19 Mexico AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 20 Mexico AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 21 Mexico AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 22 Mexico AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Europe AI in patient engagement market, by region, 2018 - 2030 (USD Million)
  • Table 24 Europe AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 25 Europe AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 26 Europe AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Europe AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 28 Europe AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Germany AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 30 Germany AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 31 Germany AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 32 Germany AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 33 Germany AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 UK AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 35 UK AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 36 UK AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 37 UK AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 38 UK AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 France AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 40 France AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 41 France AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 42 France AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 43 France AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Italy AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 45 Italy AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 46 Italy AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 47 Italy AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 48 Italy AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Spain AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 50 Spain AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 51 Spain AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 52 Spain AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 53 Spain AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Denmark AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 55 Denmark AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 56 Denmark AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 57 Denmark AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 58 Denmark AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Sweden AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 60 Sweden AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 61 Sweden AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 62 Sweden AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 63 Sweden AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 64 Norway AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 65 Norway AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 66 Norway AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 67 Norway AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 68 Norway AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Asia Pacific AI in patient engagement market, by region, 2018 - 2030 (USD Million)
  • Table 70 Asia Pacific AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 71 Asia Pacific AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 72 Asia Pacific AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 73 Asia Pacific AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 74 Asia Pacific AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 China AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 76 China AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 77 China AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 78 China AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 79 China AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 80 Japan AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 81 Japan AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 82 Japan AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 83 Japan AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 84 Japan AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 India AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 86 India AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 87 India AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 88 India AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 89 India AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 90 South Korea AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 91 South Korea AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 92 South Korea AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 93 South Korea AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 94 South Korea AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 95 Australia AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 96 Australia AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 97 Australia AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 98 Australia AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 99 Australia AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 100 Thailand AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 101 Thailand AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 102 Thailand AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 103 Thailand AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 104 Thailand AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 105 Latin America AI in patient engagement market, by region, 2018 - 2030 (USD Million)
  • Table 106 Latin America AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 107 Latin America AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 108 Latin America AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 109 Latin America AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 110 Latin America AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 111 Brazil AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 112 Brazil AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 113 Brazil AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 114 Brazil AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 115 Brazil AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 116 Argentina AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 117 Argentina AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 118 Argentina AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 119 Argentina AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 120 Argentina AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 121 MEA AI in patient engagement market, by region, 2018 - 2030 (USD Million)
  • Table 122 MEA AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 123 MEA AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 124 MEA AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 125 MEA AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 126 MEA AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 127 South Africa AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 128 South Africa AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 129 South Africa AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 130 South Africa AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 131 South Africa AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 132 Saudi Arabia AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 133 Saudi Arabia AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 134 Saudi Arabia AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 135 Saudi Arabia AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 136 Saudi Arabia AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 137 UAE AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 138 UAE AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 139 UAE AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 140 UAE AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 141 UAE AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 142 Kuwait AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 143 Kuwait AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 144 Kuwait AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 145 Kuwait AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 146 Kuwait AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Artificial intelligence in patient engagement market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Commodity flow analysis
  • Fig. 5 Parent market analysis
  • Fig. 6 Market snapshot
  • Fig. 7 Segment snapshot
  • Fig. 8 Segment snapshot
  • Fig. 9 Segment snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 AI in Patient Engagement Market Dynamics
  • Fig. 12 Major chatbot use cases in healthcare
  • Fig. 13 Advantages of omnichannel for pharmaceutical industry
  • Fig. 14 Key benefits of patient-centered care:
  • Fig. 15 Key challenges and strategies to maximize the potential of conversational AI in healthcare
  • Fig. 16 AI in patient engagement market: Porter's five forces analysis
  • Fig. 17 AI in patient engagement market: PESTLE analysis
  • Fig. 18 AI in patient engagement market, component outlook key takeaways (USD million)
  • Fig. 19 AI in patient engagement market: Technology movement analysis, 2023 & 2030 (USD Million)
  • Fig. 20 NLP market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Smart assistance market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 OCR market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Auto coding market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Text analytics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Speech analytics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Text analytics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 AI in patient engagement market, therapeutic outlook key takeaways (USD Million)
  • Fig. 29 AI in patient engagement market: Therapeutic area movement analysis, 2023 & 2030 (USD Million)
  • Fig. 30 Health & wellness market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Chronic disease management market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 AI in patient engagement market, functionality outlook key takeaways (USD Million)
  • Fig. 34 AI in patient engagement market: Functionality movement analysis, 2023 & 2030 (USD Million)
  • Fig. 35 Enhanced communication market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Patient education market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Chatbots and virtual health assistants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Predictive analytics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Administrative and streamlined operations market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 AI in patient engagement market, delivery type outlook key takeaways (USD million)
  • Fig. 42 AI in patient engagement market: Delivery type movement analysis, 2023 & 2030 (USD Million)
  • Fig. 43 Cloud-based market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 On-premise market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 AI in patient engagement market, end use outlook key takeaways (USD Million)
  • Fig. 46 AI in patient engagement market: End use movement analysis, 2023 & 2030 (USD Million)
  • Fig. 47 Healthcare providers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Healthcare payers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Regional outlook, 2023 & 2030
  • Fig. 51 Regional marketplace: Key takeaways
  • Fig. 52 Regional marketplace: Key takeaways
  • Fig. 53 North America: SWOT Analysis
  • Fig. 54 North America AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 55 U.S country dynamics
  • Fig. 56 U.S. AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 57 Canada country dynamics
  • Fig. 58 Canada AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 59 Mexico country dynamics
  • Fig. 60 Mexico AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 61 Europe: SWOT Analysis
  • Fig. 62 Europe AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 63 Germany country dynamics
  • Fig. 64 Germany AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 65 France country dynamics
  • Fig. 66 France AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 67 UK country dynamics
  • Fig. 68 UK AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 69 Italy country dynamics
  • Fig. 70 Italy AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 71 Spain country dynamics
  • Fig. 72 Spain AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 73 Denmark country dynamics
  • Fig. 74 Denmark AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 75 Sweden country dynamics
  • Fig. 76 Sweden AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 77 Norway country dynamics
  • Fig. 78 Norway AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 79 Asia Pacific: SWOT Analysis
  • Fig. 80 Asia Pacific AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 81 Japan country dynamics
  • Fig. 82 Japan AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 83 China country dynamics
  • Fig. 84 China AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 85 India country dynamics
  • Fig. 86 India AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 87 Australia country dynamics
  • Fig. 88 Australia AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 89 South Korea country dynamics
  • Fig. 90 South Korea AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 91 Thailand country dynamics
  • Fig. 92 Thailand AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 93 Latin America: SWOT Analysis
  • Fig. 94 Latin America AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 95 Brazil country dynamics
  • Fig. 96 Brazil AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 97 Argentina country dynamics
  • Fig. 98 Argentina AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 99 MEA: SWOT Analysis
  • Fig. 100 MEA AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 101 South Africa country dynamics
  • Fig. 102 South Africa AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 103 Saudi Arabia country dynamics
  • Fig. 104 Saudi Arabia AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 105 UAE country dynamics
  • Fig. 106 UAE AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 107 Kuwait country dynamics
  • Fig. 108 Kuwait AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 109 Key company categorization
  • Fig. 110 Company market position analysis
  • Fig. 111 Strategy mapping